Evaluation of the association between bevacizumab concentration and clinical outcomes in patients with breast cancer brain metastasis

Bevacizumab is widely used in various clinical indications, but investigations into its optimal dosage for treating CNS metastases remain limited. The BEEP regimen, comprising bevacizumab, etoposide, and cisplatin, has recently demonstrated promising clinical outcomes for patients with breast cancer...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Chih-Ning Cheng, Yun-Jung Tsai, Huai-Hsuan Chiu, Tom Wei-Wu Chen, Ching-Hung Lin, Yen-Sheng Lu, Ching-Hua Kuo
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2025-01-01
Serie:	Heliyon
Soggetti:	Bevacizumab Therapeutic drug monitoring Overall survival Liquid chromatography–mass spectrometry
Accesso online:	http://www.sciencedirect.com/science/article/pii/S240584402417421X
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!